ranbaxy (Citi) Strong Numbers, Aricept Led

Beats estimates; Steady revenue growth, excluding exclusivities; Margins stable; still room for improvement;
Date Rating Target Price Recommendation Price Broker house
11 May 2011 buy 700 449 Citi Report

No comments:

Post a Comment